Bardy Diagnostics is the developer of a heart monitor known as Carnation Ambulatory Monitor (CAM™) that can be worn comfortably and discreetly for up to 14 days.
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 2/14/2020 | Series B-1 | $13MM raised | $XXX.XX | $XXX.XX |
| 4/16/2019 | Series B | $35.65MM raised | $XXX.XX | $XXX.XX |
| 7/16/2018 | Series A | $35.36MM raised | $XXX.XX | $XXX.XX |
